HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thalamic involvement in patients with neurologic impairment due to Shiga toxin 2.

AbstractOBJECTIVE:
The outbreak of hemolytic-uremic syndrome and diarrhea caused by Shiga toxin-producing Escherichia coli O104:H4 in Germany during May to July 2011 involved severe and characteristic neurologic manifestations with a strong female preponderance. Owing to these observations, we designed a series of experimental studies to evaluate the underlying mechanism of action of this clinical picture.
METHODS:
A magnetic resonance imaging and electroencephalographic study of patients was performed to evaluate the clinical picture in detail. Thereafter, combinations of different experimental settings, including electrophysiological and histological analyses, as well as calcium imaging in brain slices of rats, were conducted.
RESULTS:
We report on 7 female patients with neurologic symptoms and signs including bilateral thalamic lesions and encephalopathic changes indicative of a predominant involvement of the thalamus. Experimental studies in rats revealed an enhanced expression of the Shiga toxin receptor globotriaosylceramide on thalamic neurons in female rats as compared to other brain regions in the same rats and to male animals. Incubation of brain slices with Shiga toxin 2 evoked a strong membrane depolarization and intracellular calcium accumulation in neurons, associated with neuronal apoptosis, predominantly in the thalamic area.
INTERPRETATION:
These findings suggest that the direct cytotoxic effect of Shiga toxin 2 in the thalamus might contribute to the pathophysiology of neuronal complications in hemolytic-uremic syndrome.
AuthorsSven G Meuth, Kerstin Göbel, Tatyana Kanyshkova, Petra Ehling, Martin A Ritter, Wolfram Schwindt, Martina Bielaszewska, Pia Lebiedz, Philippe Coulon, Alexander M Herrmann, Wiebke Storck, Denise Kohmann, Johannes Müthing, Hermann Pavenstädt, Tanja Kuhlmann, Helge Karch, Georg Peters, Thomas Budde, Heinz Wiendl, Hans-Christian Pape
JournalAnnals of neurology (Ann Neurol) Vol. 73 Issue 3 Pg. 419-29 (Mar 2013) ISSN: 1531-8249 [Electronic] United States
PMID23424019 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 American Neurological Association.
Chemical References
  • RNA, Messenger
  • Shiga Toxin 2
  • Trihexosylceramides
  • globotriaosylceramide
  • Calcium
Topics
  • Adult
  • Aged
  • Animals
  • Animals, Newborn
  • Apoptosis (drug effects)
  • Astrocytes (drug effects, metabolism)
  • Calcium (metabolism)
  • Electroencephalography
  • Escherichia coli Infections (cerebrospinal fluid, complications)
  • Female
  • Gene Expression Regulation (drug effects)
  • Humans
  • In Vitro Techniques
  • Magnetic Resonance Imaging
  • Membrane Potentials (drug effects)
  • Nervous System Diseases (cerebrospinal fluid, etiology, pathology)
  • Neurons (drug effects)
  • Patch-Clamp Techniques
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Long-Evans
  • Sex Characteristics
  • Shiga Toxin 2 (toxicity)
  • Thalamus (pathology, physiopathology)
  • Trihexosylceramides (metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: